PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ETHSX vs. NVDA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between ETHSX and NVDA is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

ETHSX vs. NVDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eaton Vance Worldwide Health Sciences Fund (ETHSX) and NVIDIA Corporation (NVDA). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
-7.49%
4.29%
ETHSX
NVDA

Key characteristics

Sharpe Ratio

ETHSX:

0.17

NVDA:

2.66

Sortino Ratio

ETHSX:

0.31

NVDA:

3.09

Omega Ratio

ETHSX:

1.04

NVDA:

1.38

Calmar Ratio

ETHSX:

0.14

NVDA:

5.19

Martin Ratio

ETHSX:

0.36

NVDA:

15.75

Ulcer Index

ETHSX:

5.18%

NVDA:

8.92%

Daily Std Dev

ETHSX:

11.22%

NVDA:

52.97%

Max Drawdown

ETHSX:

-45.11%

NVDA:

-89.73%

Current Drawdown

ETHSX:

-12.63%

NVDA:

-11.82%

Returns By Period

In the year-to-date period, ETHSX achieves a 1.16% return, which is significantly higher than NVDA's -1.88% return. Over the past 10 years, ETHSX has underperformed NVDA with an annualized return of 3.73%, while NVDA has yielded a comparatively higher 75.64% annualized return.


ETHSX

YTD

1.16%

1M

-1.87%

6M

-7.49%

1Y

1.95%

5Y*

6.19%

10Y*

3.73%

NVDA

YTD

-1.88%

1M

-1.85%

6M

4.29%

1Y

140.88%

5Y*

84.74%

10Y*

75.64%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ETHSX vs. NVDA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ETHSX
The Risk-Adjusted Performance Rank of ETHSX is 2121
Overall Rank
The Sharpe Ratio Rank of ETHSX is 2121
Sharpe Ratio Rank
The Sortino Ratio Rank of ETHSX is 2222
Sortino Ratio Rank
The Omega Ratio Rank of ETHSX is 2020
Omega Ratio Rank
The Calmar Ratio Rank of ETHSX is 2525
Calmar Ratio Rank
The Martin Ratio Rank of ETHSX is 1818
Martin Ratio Rank

NVDA
The Risk-Adjusted Performance Rank of NVDA is 9595
Overall Rank
The Sharpe Ratio Rank of NVDA is 9797
Sharpe Ratio Rank
The Sortino Ratio Rank of NVDA is 9393
Sortino Ratio Rank
The Omega Ratio Rank of NVDA is 9191
Omega Ratio Rank
The Calmar Ratio Rank of NVDA is 9898
Calmar Ratio Rank
The Martin Ratio Rank of NVDA is 9696
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ETHSX vs. NVDA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Eaton Vance Worldwide Health Sciences Fund (ETHSX) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ETHSX, currently valued at 0.17, compared to the broader market-1.000.001.002.003.004.000.172.66
The chart of Sortino ratio for ETHSX, currently valued at 0.31, compared to the broader market0.002.004.006.008.0010.000.313.09
The chart of Omega ratio for ETHSX, currently valued at 1.04, compared to the broader market1.002.003.001.041.38
The chart of Calmar ratio for ETHSX, currently valued at 0.14, compared to the broader market0.005.0010.0015.000.145.19
The chart of Martin ratio for ETHSX, currently valued at 0.36, compared to the broader market0.0020.0040.0060.000.3615.75
ETHSX
NVDA

The current ETHSX Sharpe Ratio is 0.17, which is lower than the NVDA Sharpe Ratio of 2.66. The chart below compares the historical Sharpe Ratios of ETHSX and NVDA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.00AugustSeptemberOctoberNovemberDecember2025
0.17
2.66
ETHSX
NVDA

Dividends

ETHSX vs. NVDA - Dividend Comparison

ETHSX's dividend yield for the trailing twelve months is around 0.18%, more than NVDA's 0.02% yield.


TTM20242023202220212020201920182017201620152014
ETHSX
Eaton Vance Worldwide Health Sciences Fund
0.18%0.19%0.13%0.21%0.24%0.51%0.58%0.34%0.00%0.00%0.00%0.00%
NVDA
NVIDIA Corporation
0.02%0.02%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%1.70%

Drawdowns

ETHSX vs. NVDA - Drawdown Comparison

The maximum ETHSX drawdown since its inception was -45.11%, smaller than the maximum NVDA drawdown of -89.73%. Use the drawdown chart below to compare losses from any high point for ETHSX and NVDA. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-12.63%
-11.82%
ETHSX
NVDA

Volatility

ETHSX vs. NVDA - Volatility Comparison

The current volatility for Eaton Vance Worldwide Health Sciences Fund (ETHSX) is 3.42%, while NVIDIA Corporation (NVDA) has a volatility of 12.15%. This indicates that ETHSX experiences smaller price fluctuations and is considered to be less risky than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
3.42%
12.15%
ETHSX
NVDA
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab